D
David M. Vock
Researcher at University of Minnesota
Publications - 152
Citations - 3516
David M. Vock is an academic researcher from University of Minnesota. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 27, co-authored 130 publications receiving 2613 citations. Previous affiliations of David M. Vock include Duke University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander J. Thompson,Andrew J. Muir,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas J. Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem Ghalib,B. Freilich,L. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Keyur Patel,Hans L. Tillmann,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David Goldstein,John G. McHutchison,John G. McHutchison +38 more
TL;DR: In treatment-naive HCV-1 patients treated with pegylated interferon and ribavirin, a polymorphism upstream of IL-28B is associated with increased on-treatment and sustained virologic response and effectively predicts treatment outcome.
Journal ArticleDOI
Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration
Anne M. Joseph,Alexander J. Rothman,Daniel Almirall,Abbie Begnaud,Caroline Chiles,Paul M. Cinciripini,Steven S. Fu,Amanda L. Graham,Bruce R. Lindgren,Anne C. Melzer,Jamie S. Ostroff,Elizabeth L. Seaman,Kathryn L. Taylor,Benjamin A. Toll,Steven B. Zeliadt,David M. Vock +15 more
TL;DR: The SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaborative Trial as mentioned in this paper is an example of a large-scale clinical trial with a focus on lung cancer screening.
Journal ArticleDOI
Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients
Hesham Elhalawani,Aasheesh Kanwar,Aasheesh Kanwar,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,A. White,A. White,James Zafereo,James Zafereo,Andrew J. Wong,Andrew J. Wong,Joel Berends,Joel Berends,Shady Abohashem,Shady Abohashem,Bowman Williams,Bowman Williams,Jeremy M. Aymard,Jeremy M. Aymard,Subha Perni,Subha Perni,J.A. Messer,Ben Warren,Bassem Youssef,Pei Yang,Pei Yang,M.A.M. Meheissen,M.A.M. Meheissen,Mona Kamal,Mona Kamal,Baher Elgohari,Baher Elgohari,Rachel B. Ger,Rachel B. Ger,Carlos E. Cardenas,X Fave,Lifei Zhang,Dennis Stephen Mackin,G. Elisabeta Marai,David M. Vock,Guadalupe Canahuate,Stephen Y. Lai,G. Brandon Gunn,Adam S. Garden,David I. Rosenthal,Laurence E. Court,Clifton D. Fuller +46 more
TL;DR: It is hypothesize that certain textural features of oropharyngeal cancer (OPC) primary tumors will have statistically significant correlations to patient outcomes such as local control.
Journal ArticleDOI
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Richard T. Davey,Eduardo Fernández-Cruz,Norman Markowitz,Sarah Pett,Abdel Babiker,Deborah Wentworth,Surender Khurana,Nicole Engen,Fred M. Gordin,Mamta K. Jain,Virginia L. Kan,Mark N. Polizzotto,Paul F. Riska,Kiat Ruxrungtham,Zelalem Temesgen,Jens D Lundgren,John H. Beigel,H. Clifford Lane,James D. Neaton,Jessica Butts,Eileen Denning,Alain DuChene,Eric A. Krum,Merrie Harrison,Sue Meger,Ross L. Peterson,Kien Quan,Megan Shaughnessy,Greg Thompson,David M. Vock,Julia A. Metcalf,Robin Dewar,Tauseef Rehman,Ven Natarajan,Rose McConnell,Emily Flowers,Kenny Smith,Marie Hoover,Elizabeth M Coyle,David Munroe,Bitten Aagaard,Mary Pearson,Adam Cursley,Helen Webb,Fleur Hudson,Charlotte Russell,Aminata Sy,Cara Purvis,Brooke Jackson,Yolanda Collaco-Moraes,Dianne Carey,Rosemary Robson,Adriana Sánchez,Elizabeth Finley,Donna Conwell,Marcelo H. Losso,Luciana Gambardella,Cecilia Abela,Paco Lopez,Helena Alonso,Giota Touloumi,Vicky Gioukari,Olga Anagnostou,Anchalee Avihingsanon,Kanitta Pussadee,Sasiwimol Ubolyam,Bola Omotosho,Clemencia Solórzano,Tianna Petersen,Kranthi Vysyaraju,Stacey A Rizza,Jennifer A Whitaker,Raquel Nahra,John D. Baxter,Patricia Coburn,Edward M. Gardner,James A Scott,Leslie Faber,Erica Pastor,Linda Makohon,Rodger A MacArthur,L Monique Hillman,Marti J Farrough,Hari M Polenakovik,Linda A Clark,Roberto J Colon,Ken M. Kunisaki,Miranda DeConcini,Susan A Johnson,Cameron R. Wolfe,Laura Mkumba,June Y Carbonneau,Alison Morris,Meghan Fitzpatrick,Cathy J Kessinger,Robert A. Salata,Karen A Arters,Catherine M Tasi,Ralph J. Panos,Laura A Lach,Marshall J. Glesby,Kirsis Ham,Valery G Hughes,Robert T. Schooley,Daniel Crouch,Leticia Muttera,Richard M. Novak,Susan C Bleasdale,Ariel E Zuckerman,Weerawat Manosuthi,Supeda Thaonyen,Thaniya Chiewcharn,Gompol Suwanpimolkul,Sivaporn Gatechumpol,Sirikunya Bunpasang,Brian Angus,Monique Anderson,Marcus Morgan,Jane Minton,Maria N Gkamaletsou,Joe Hambleton,David Price,Martin J Llewelyn,Jonathan Sweetman,Javier Carbone,Jose R. Arribas,Rocio Montejano,Jose L Lobo Beristain,Iñaki Z Martinez,Jose Barberan,Paola Hernandez,Dominic E. Dwyer,Jen Kok,Álvaro H. Borges,Christian Brandt,Lene S Knudsen,Nikolaos Sypsas,Costas S. Constantinou,Antonios Markogiannakis,Spyros Zakynthinos,Paraskevi Katsaounou,Ioannis Kalomenidis,Analia Mykietiuk,Maria F Alzogaray,Mora Obed,Laura Moreno Macias,Juan Ebensrtejin,Patricia Burgoa,Esteban C. Nannini,Matias Lahitte,Santiago Perez-Patrigeon,José Arturo Martínez-Orozco,Juan Pablo Ramírez-Hinojosa +152 more
TL;DR: In this article, the authors evaluated the safety and efficacy of intravenous immunoglobulin (HIVIG) in a randomized controlled trial. But, they did not evaluate the effect of the infusion of high-titre hIVIG on clinical outcomes.
Journal ArticleDOI
Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival
Rebecca D. Kehm,Logan G. Spector,Jenny N. Poynter,David M. Vock,Sean F. Altekruse,Theresa L. Osypuk +5 more
TL;DR: This study applied mediation methods to quantify the role of SES in racial/ethnic differences in childhood cancer survival, and found that among non‐Hispanic blacks and Hispanics, SES is higher than among non-Hispanic whites.